Arthur Yin
Internal Medicine · Richmond, KYNPI 1144241233
Payments from drug & device makers
Across 168 payments — averaging $13.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$269
- AstraZeneca$237
- GSK$226
- Johnson & Johnson$224
- Pfizer$222
- Lilly USA, LLC$181
- plus $990 from 20 others
What the payments were for
- Food & beverage$2,31599%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $269 |
| AstraZeneca | 13 | $237 |
| GSK | 15 | $226 |
| Johnson & Johnson | 10 | $224 |
| Pfizer | 17 | $222 |
| Lilly USA, LLC | 15 | $181 |
| Astellas Pharma US Inc | 11 | $170 |
| Amgen | 13 | $168 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $117 |
| AbbVie(2 entities) | 6 | $100 |
| Boehringer Ingelheim | 7 | $96 |
| Xeris Pharmaceuticals, Inc. | 5 | $71 |
| Novartis | 3 | $43 |
| Sanofi-aventis U.S. LLC | 3 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Insulet Corporation | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $11 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$206
How this compares
$2,349 in reported general payments places this provider in the 75th percentile of 1,284 internal medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 15 | $18,438 |
| Atorvastatin Calcium | 63 | $403 |
| Levothyroxine Sodium | 21 | $366 |
| Omeprazole | 32 | $265 |
| Bupropion XlBupropion Hcl | 12 | $261 |
| Losartan Potassium | 21 | $212 |
| Amlodipine Besylate | 29 | $173 |
| Tamsulosin Hcl | 16 | $167 |
| Pantoprazole Sodium | 11 | $164 |
| Lisinopril | 31 | $152 |
| Potassium Chloride | 11 | $148 |
| Carvedilol | 14 | $87 |
| Sertraline Hcl | 11 | $57 |
| Metformin Hcl | 19 | $52 |
| Montelukast Sodium | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $96 | $18,43815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Richmond
- Gaurang ShahRichmond$14K
- Mark AdamsLondon$15.4M
- Matthew WenkerErlanger$12.8M
- Jason ChesneyLouisville$6.3M
- Neil FarrisLexington$3M
- David JohnsonOwensboro$787K
- Hollis ClarkMurray$780K
- Fares KhaterWhitesburg$412K
- Christopher PhillipsPaducah$315K
- Cynthia Bowman-StroudPaducah$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.